TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients
Clinical trial NCT04066543 · UNKNOWN
Trial details
- NCT number
- NCT04066543
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-30
- Primary completion
- 2021-05-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.